Bridges Investment Counsel’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$517K Buy
+6,405
New +$513K 0.29% 83
2017
Q3
Sell
-2,945
Closed -$262K 136
2017
Q2
$262K Buy
+2,945
New +$248K 0.06% 135
2017
Q1
Sell
-3,945
Closed -$281K 138
2016
Q4
$281K Hold
3,945
0.07% 129
2016
Q3
$341K Hold
3,945
0.07% 122
2016
Q2
$342K Sell
3,945
-1,012
-20% -$81.8K 0.08% 124
2016
Q1
$372K Sell
4,957
-1,646
-25% -$124K 0.08% 124
2015
Q4
$490K Hold
6,603
0.09% 101
2015
Q3
$490K Sell
6,603
-570
-8% -$42K 0.09% 101
2015
Q2
$531K Sell
7,173
-150
-2% -$11.5K 0.12% 116
2015
Q1
$571K Buy
+7,323
New +$555K 0.13% 116

Other funds holding MDT

Bridges Investment Counsel's MDT Position: Q4 2017 in Review

Bridges Investment Counsel opened a new position in Medtronic (MDT) in Q4 2017: 6,405 shares worth $517K. The stake represents 0.29% of the portfolio and ranks #83 among its holdings. This is a return to the name: Bridges Investment Counsel previously reported a position in MDT as recently as Q2 2017.

Bridges Investment Counsel first reported a position in MDT in Q1 2015 and has held it in 10 quarters since. The position peaked at $571K in Q1 2015. 1,408 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

  • Bridges Investment Counsel held 6,405 shares of Medtronic worth $517K as of Q4 2017.
  • Medtronic was a new Bridges Investment Counsel position in Q4 2017.
  • Medtronic made up 0.29% of Bridges Investment Counsel's portfolio in Q4 2017, its #83 holding.
  • Bridges Investment Counsel first reported a position in Medtronic in Q1 2015 and has held it in 10 quarters since.
  • Bridges Investment Counsel's Medtronic position peaked at $571K in Q1 2015.
  • 1,408 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.